Gilead Sciences, Inc.: Access Program
通常価格
¥1,408 JPY
通常価格
セール価格
¥1,408 JPY
単価
あたり
To maximize their effectiveness, color cases should be printed in color. Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients by the middle of 2009, the company's senior managers contemplated how to reach 2 million patients by 2012.
【書誌情報】
ページ数:25ページ
サイズ:A4
商品番号:HBSP-510029
発行日:2009/10/8
登録日:2010/8/17